Suppression of hydroxyl radical formation and protection of nigral neurons by l-deprenyl (selegiline)
- PMID: 8687036
- DOI: 10.1111/j.1749-6632.1996.tb39078.x
Suppression of hydroxyl radical formation and protection of nigral neurons by l-deprenyl (selegiline)
Abstract
The present study clearly demonstrated that l-deprenyl confers a substantial protective effect against MPP+ in the substantia nigra zona compacta in vivo. 32.39. The protection provided by l-deprenyl may not depend on its inhibition of type B monoamine oxidase. A unique antioxidant property of l-deprenyl by suppression of cycotoxic. OH formation and associated oxidative damage induced by MPP+ in the A9 melanized nigral neurons may contribute to the protection against MPP+ toxicity in the nigrostriatal system. The likelihood that l-deprenyl may confer neuroprotection against MPP+ toxicity through antioxidant effect is further strongly supported by our recent data that U-78517F (2-methlaminochromans) a potent inhibitor of ironcatalyzed lipid peroxidation, and DMSO an effective. OH scavenger also protect nigral neurons against MPP(+)-induced severe oxidative injury in the substantia nigra. This putative antioxidant effect of deprenyl may explore another mechanism which may in part contribute to its overt neuroprotection against several toxins, including 6-OHDA, DSP-4, and MPTP, and the possible clinical effects on slowing the neuronal degeneration in early Parkinson's disease, Alzheimer's disorder and even senescent changes.
Similar articles
-
Antioxidant mechanism and protection of nigral neurons against MPP+ toxicity by deprenyl (selegiline).Ann N Y Acad Sci. 1994 Nov 17;738:214-21. doi: 10.1111/j.1749-6632.1994.tb21806.x. Ann N Y Acad Sci. 1994. PMID: 7832430 Review.
-
Apparent antioxidant effect of l-deprenyl on hydroxyl radical formation and nigral injury elicited by MPP+ in vivo.Eur J Pharmacol. 1993 Oct 26;243(3):241-7. doi: 10.1016/0014-2999(93)90181-g. Eur J Pharmacol. 1993. PMID: 8276076
-
D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.Synapse. 2003 Oct;50(1):7-13. doi: 10.1002/syn.10239. Synapse. 2003. PMID: 12872288
-
Neuronal protective and rescue effects of deprenyl against MPP+ dopaminergic toxicity.J Neural Transm Gen Sect. 1995;100(1):53-61. doi: 10.1007/BF01276865. J Neural Transm Gen Sect. 1995. PMID: 8748663
-
In vivo generation of hydroxyl radicals and MPTP-induced dopaminergic toxicity in the basal ganglia.Ann N Y Acad Sci. 1994 Nov 17;738:25-36. doi: 10.1111/j.1749-6632.1994.tb21786.x. Ann N Y Acad Sci. 1994. PMID: 7832434 Review.
Cited by
-
Age-related protective effect of deprenyl on changes in the levels of diagnostic marker enzymes and antioxidant defense enzymes activities in cerebellar tissue in Wistar rats.Cell Stress Chaperones. 2010 Sep;15(5):743-51. doi: 10.1007/s12192-010-0177-y. Epub 2010 Mar 13. Cell Stress Chaperones. 2010. PMID: 20224915 Free PMC article.
-
Tyrosine hydroxylase and Parkinson's disease.Mol Neurobiol. 1998 Jun;16(3):285-309. doi: 10.1007/BF02741387. Mol Neurobiol. 1998. PMID: 9626667 Review.
-
Neuroprotective strategies in Parkinson's disease : an update on progress.CNS Drugs. 2003;17(10):729-62. doi: 10.2165/00023210-200317100-00004. CNS Drugs. 2003. PMID: 12873156 Review.
-
MAO-B elevation in mouse brain astrocytes results in Parkinson's pathology.PLoS One. 2008 Feb 20;3(2):e1616. doi: 10.1371/journal.pone.0001616. PLoS One. 2008. PMID: 18286173 Free PMC article.
-
An inducible MAO-B mouse model of Parkinson's disease: a tool towards better understanding basic disease mechanisms and developing novel therapeutics.J Neural Transm (Vienna). 2018 Nov;125(11):1651-1658. doi: 10.1007/s00702-018-1887-z. Epub 2018 Apr 30. J Neural Transm (Vienna). 2018. PMID: 29713806 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous